Centre Hospitalier de St Nazaire
Saint-Nazaire, 44606, France
NCT Number: NCT02841852
Proton pump inhibitors (PPIs) are one of the most frequently prescribed classes of drugs in the world and the most effective drugs available to reduce gastric acid secretion. However, studies have shown that PPIs are not always prescribed with a clear indication. Indeed, between 25% and 86% of older individuals taking a PPI have been overprescribed these medications. In older patients, overprescribing of a PPI is associated with increases in morbidity, adverse drug events, hospitalization, and mortality. The hypothesis is that overprescription of PPIs is associated with the individual multimorbidities in older patients evaluated using the multimorbidities group criteria included in the CIRS. The aim of the present study was to establish a relationship between overprescribing of PPIs and multimorbidities in older patients.
Looking for future studies?
Notify Me75 year and older
All sexes
Observational
Saint-Nazaire, 44606, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 48 hours after the entry into acute geriatric medicine
Burden of comorbidities is assessed by the CIRS (Cumulative Illness Rating Scale)
Nantes University Hospital
Other
Inappropriate Prescribing of Proton-pump Inhibitor is it Associated With the Burden of Comorbidities in Older Patients Over 75 Years Old ?
Acronym: IPP SA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02949635
Geriatric Disorder
Amiens, France
View Trial DetailsNCT02928107
Ear Diseases, Geriatric Disorder
Ann Arbor, Michigan, United States
View Trial DetailsNCT02737839
Cancer, Geriatric Disorder
St Louis, Missouri, United States
View Trial DetailsNCT02664948
Geriatric Disorder
Aarhus, Central Jutland, Denmark
View Trial Details